
From Conventional to Advanced Therapies: A National Health Registry Report (2016-2022) on DMARDs in Rheumatoid Arthritis ...
Key Points 1. Etanercept and β-blocker treatments have the longest duration of use based on real-life data. 2. Biosimilar usage rates vary between 10.8 and 27.7% among their drug groups. 3. Real-life data is considered to select the most effective and long …